Who was studied, and how
Three numbers in the abstract
Where each one falls
Only readable comparisons vote
Where it lands on the map
What it changes
Among 4 other studies
1,000people in the Statins and Noncardiovascular Endpoints trial, from 2000
of them with hypertension, in this paper
The trial randomly assignedassigned by chance
statins
placebo
Reported lower systolic blood pressure, no range given−2.20
Reported lower diastolic blood pressure, no range given−2.40
randomisedAmong subjects with full follow-up, and without potential for influence by BP medications (ie, neither receiving nor meriting BP medications), the trial randomly assignedassigned by chance
simvastatin and pravastatin
placebo
Reported lower SBP and DBP, no range given−2.40
randomisedthe abstract, start to end
… reduced BP relative to placebo,by 2.2 mm Hg for SBP (P=.02) and 2.4 mm Hg for DBP (P<.001) in ITT …
Blood pressure reductions ranged from 2.4 to 2.8 mm Hg for both SBP and …
← favours treatmentfavours comparator →
could be chanceNo interval given · direction only, strength unknown
SBPstatins vs placebo
−2.20
DBPstatins vs placebo
−2.40
SBP and DBPsimvastatin and pravastatin vs placebo, in subjects with full follow-up, and without potential for influence by BP medications (ie, neither receiving nor meriting BP medications)
−2.40
StatinsBlood pressure
Statins × blood pressurehelps?replicated
unlikelylikely
0.800.50 without it
← favours comparatorfavours treatment →
1 / 7